[更年期不同激素替代疗法中的肝脏变化]
[Hepatic changes in different hormone replacement therapies in climacteric].
作者信息
Foth D, Römer T, Panzig E
机构信息
Klinik für Frauenhelikunde und Geburtshilfe.
出版信息
Zentralbl Gynakol. 1995;117(7):349-52.
PMID:7668064
Abstract
Measurements of liver enzymes (ASAT, ALAT, GGT, AP) and SHBG were carried out in 128 postmenopausal women during 12 months of different hormone replacement therapies. There was no negative effect on these liver enzymes. ASAT, ALAT, GGT and AP decreased during the 12 months of treatment. Transdermal replacement therapy did not induce a higher level of SHBG.
摘要
在128名绝经后女性接受12个月不同激素替代疗法期间，对其肝酶（谷草转氨酶、谷丙转氨酶、γ-谷氨酰转肽酶、碱性磷酸酶）和性激素结合球蛋白进行了测量。这些激素替代疗法对这些肝酶没有负面影响。在治疗的12个月期间，谷草转氨酶、谷丙转氨酶、γ-谷氨酰转肽酶和碱性磷酸酶有所下降。经皮替代疗法并未诱导更高水平的性激素结合球蛋白。
Zotero 插件